Davis Polk advised the representatives of the underwriters, in connection with the offering of €1 billion aggregate principal amount of notes issued by Merck & Co., Inc. The notes were offered in two tranches, maturing in 2024 and 2036.

Merck is a global health care leader that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which it markets directly and through its joint ventures in more than 140 countries.

The Davis Polk capital markets team included partners Richard A. Drucker and Sophia Hudson and associates Jennifer Ying Lan, Brandon Une and Matthew M. Funk. The tax team included partner Lucy W. Farr and associate Isaac MacDonald. The environmental team included counsel Loyti Cheng and associate Yuko Masunaga. Partner Frank J. Azzopardi provided intellectual property and technology advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post